The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation
Breast cancer is the most commonly diagnosed malignancy in women. Analysis of breast cancer genomic DNA indicates frequent loss-of-function mutations in components of the cJUN NH2-terminal kinase (JNK) signaling pathway. Since JNK signaling can promote cell proliferation by activating the AP1 transc...
Main Authors: | Nomeda Girnius, Yvonne JK Edwards, David S Garlick, Roger J Davis |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2018-06-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/36389 |
Similar Items
-
Excitatory transmission onto AgRP neurons is regulated by cJun NH2-terminal kinase 3 in response to metabolic stress
by: Santiago Vernia, et al.
Published: (2016-02-01) -
JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses
by: Anders Sundqvist, et al.
Published: (2019-11-01) -
The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases
by: Jing Chen, et al.
Published: (2021-09-01) -
c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1
by: Jang-Eun Cho1, Sangjung Park2, Sang-Nae Cho3, Hyeyoung Lee2 & Yoon Suk Kim2,*
Published: (2012-10-01) -
NLRP12 suppresses hepatocellular carcinoma via downregulation of cJun N-terminal kinase activation in the hepatocyte
by: SM Nashir Udden, et al.
Published: (2019-04-01)